TTK Healthcare Limited Market Cap ($141.74 Million)
Market Cap & Net Worth: TTK Healthcare Limited (TTKHLTCARE)
TTK Healthcare Limited market cap. TTK Healthcare Limited (NSE:TTKHLTCARE) has a market capitalization of $141.74 Million (Rs13.11 Billion) as of November 5, 2026. Listed on the NSE stock exchange, this India-based company holds position #17689 globally and #942 in its home market, demonstrating a -7.11% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying TTK Healthcare Limited's stock price Rs927.50 by its total outstanding shares 14130333 (14.13 Million). Also see TTKHLTCARE cash flow metrics for how efficiently the company converts equity into cash flow.
TTK Healthcare Limited Market Cap History (2015–2026)
TTK Healthcare Limited market cap history from 2015 to 2026. Data shows growth from $149.70 Million to $141.74 Million (2.08% CAGR). Check TTKHLTCARE live share price for real-time trading data and today's change.
TTK Healthcare Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how TTK Healthcare Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore TTK Healthcare Limited annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.02x
TTK Healthcare Limited's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.22x
TTK Healthcare Limited's market cap is 0.22 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $119.64 Million | $5.30 Billion | $193.34 Million | 0.02x | 0.62x |
| 2018 | $115.53 Million | $5.76 Billion | $181.65 Million | 0.02x | 0.64x |
| 2019 | $70.39 Million | $6.26 Billion | $243.74 Million | 0.01x | 0.29x |
| 2020 | $87.40 Million | $6.45 Billion | $123.19 Million | 0.01x | 0.71x |
| 2021 | $105.16 Million | $4.76 Billion | $464.41 Million | 0.02x | 0.23x |
| 2022 | $151.53 Million | $5.99 Billion | $415.88 Million | 0.03x | 0.36x |
| 2023 | $215.07 Million | $7.25 Billion | $6.40 Billion | 0.03x | 0.03x |
| 2024 | $215.09 Million | $7.48 Billion | $628.42 Million | 0.03x | 0.34x |
| 2025 | $158.74 Million | $8.73 Billion | $816.57 Million | 0.02x | 0.19x |
| 2026 | $141.74 Million | $8.57 Billion | $656.80 Million | 0.02x | 0.22x |
Competitor Companies of TTKHLTCARE by Market Capitalization
Companies near TTK Healthcare Limited in the global market cap rankings as of November 5, 2026. Also see TTK Healthcare Limited balance sheet assets for a full breakdown of the balance sheet.
Key companies related to TTK Healthcare Limited by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #12 globally with a market cap of $1.06 Trillion USD.
- Eli Lilly and Company (SA:LILY34): Ranked #20 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
- Johnson & Johnson (NYSE:JNJ): Ranked #29 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #43 globally with a market cap of $356.49 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #12 | Eli Lilly and Company | NYSE:LLY | $1.06 Trillion | $1417.99 |
| #20 | Eli Lilly and Company | SA:LILY34 | $853.51 Billion | R$153.70 |
| #29 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $276.32 |
| #43 | AbbVie Inc | NYSE:ABBV | $356.49 Billion | $294.83 |
Market Capitalization of TTK Healthcare Limited (2015–2026)
Market capitalization of TTK Healthcare Limited from 2015 to today. Between 2015 and today, TTK Healthcare Limited's market cap moved from $149.70 Million to $ 141.74 Million, with a yearly change of 2.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs141.74 Million | -10.71% |
| 2025 | Rs158.74 Million | -26.20% |
| 2024 | Rs215.09 Million | +0.01% |
| 2023 | Rs215.07 Million | +41.93% |
| 2022 | Rs151.53 Million | +44.10% |
| 2021 | Rs105.16 Million | +20.32% |
| 2020 | Rs87.40 Million | +24.17% |
| 2019 | Rs70.39 Million | -39.07% |
| 2018 | Rs115.53 Million | -3.44% |
| 2017 | Rs119.64 Million | -5.30% |
| 2016 | Rs126.34 Million | -15.60% |
| 2015 | Rs149.70 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of TTK Healthcare Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $141.74 Million USD |
| MoneyControl | $141.74 Million USD |
| MarketWatch | $141.74 Million USD |
| marketcap.company | $141.74 Million USD |
| Reuters | $141.74 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About TTK Healthcare Limited
TTK Healthcare Limited engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Foods, Protective Devices and Other segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, antiparasiticides, antisp… Read more